Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring
Introduction Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy o...
Gespeichert in:
Veröffentlicht in: | European journal of nuclear medicine and molecular imaging 2010-08, Vol.37 (9), p.1643-1653 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1653 |
---|---|
container_issue | 9 |
container_start_page | 1643 |
container_title | European journal of nuclear medicine and molecular imaging |
container_volume | 37 |
creator | Murray, Iain Kalemis, Antonis Glennon, Joe Hasan, Syed Quraishi, Shuaib Beyer, Thomas Avril, Norbert |
description | Introduction
Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy of quantitative measures using time-of-flight PET/CT.
Methods
We evaluated the effect of reducing the emission count statistics, using a 64-channel GEMINI TF PET/CT system. Experiments were performed with the NEMA IEC body phantom at target-to-background ratios of 4:1 and 10:1. Emission data for 10 s, 30 s, 1 min, 2 min, 5 min and 30 min were acquired. Volumes of interest fitted to the CT outline of the spheres were used to calculate recovery coefficients for each target-to-background ratio and for different reconstruction algorithms. Whole-body time-of-flight PET/CT was performed in 20 patients 62±4 min after injection of 350±40 MBq (range 269–411 MBq)
18
F-FDG. From the acquired 2 min per bed position list mode data, simulated 1-min, 30-s and 15-s PET acquisitions were created. PET images were reconstructed using the TOF-OSEM algorithm and analysed for differences in SUV measurements resulting from the use of lower administered activity as simulated by reduced count statistics.
Results
In the phantom studies, overall we identified no significant quantitation bias over a wide range of acquired counts. With acquisition times as short as 10 s, lesions as small as 1 cm in diameter could still be identified. In the patient studies, visual analysis showed that emission scans as short as 15 s per bed position sufficiently identified tumour lesions for quantification. As the acquisition time per bed position decreased, the differences in SUV quantification of tumour lesions increased relative to the 2-min reference protocol. However, SUVs remained within the limits of reproducibility required for therapy monitoring. Measurements of SUVmean within the region of interest were less prone to noise than SUVmax, and with the 30-s per bed position 95% confidence limits were ±11% or ±0.7 SUV.
Conclusion
Short time acquisitions, synonymous with reduced injected activity, performed on a TOF-based PET/CT system are feasible without encountering significant bias. This could translate into clinical protocols using lower administered activities particularly for serial PET studies. |
doi_str_mv | 10.1007/s00259-010-1466-5 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_748927237</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>748927237</sourcerecordid><originalsourceid>FETCH-LOGICAL-c436t-85778430854d8d58f17654e685c51c1da2e5f22021011d0ac925bbbcaac4437f3</originalsourceid><addsrcrecordid>eNp1kUFrGzEQhUVJaRwnP6CXIHLpSfVIK620uQXjpoVAe3DPQtZqbYXd1UbSpvjfd41dBwI9zQx88-YxD6HPFL5SALlIAExUBCgQysuSiA9oRktaEQmqujj3Ei7RVUrPAFQxVX1Clww4U6osZ2i39p0joSFN67e7jH-t1ovlGo_J91vchj_E2Oxffd7jIYYcbGjTPR5Cdn32psW-G1pvTfahT7gJEVvTWxdx3rlohj3uQu9ziJPYNfrYmDa5m1Odo9_fVuvld_L08_HH8uGJWF6UmSghpeIFKMFrVQvVUFkK7kolrKCW1oY50TAGjAKlNRhbMbHZbKwxlvNCNsUcfTnqTn5fRpey7nyyrm1N78KYtOSqYpIVciLv3pHPYYz9ZE4ryahkqqgmiB4hG0NK0TV6iL4zca8p6EMI-hiChsM8haDFtHN7Eh43navPG_--PgHsCKTh8BoX3y7_X_UvIL2R9A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>872172839</pqid></control><display><type>article</type><title>Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Murray, Iain ; Kalemis, Antonis ; Glennon, Joe ; Hasan, Syed ; Quraishi, Shuaib ; Beyer, Thomas ; Avril, Norbert</creator><creatorcontrib>Murray, Iain ; Kalemis, Antonis ; Glennon, Joe ; Hasan, Syed ; Quraishi, Shuaib ; Beyer, Thomas ; Avril, Norbert</creatorcontrib><description>Introduction
Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy of quantitative measures using time-of-flight PET/CT.
Methods
We evaluated the effect of reducing the emission count statistics, using a 64-channel GEMINI TF PET/CT system. Experiments were performed with the NEMA IEC body phantom at target-to-background ratios of 4:1 and 10:1. Emission data for 10 s, 30 s, 1 min, 2 min, 5 min and 30 min were acquired. Volumes of interest fitted to the CT outline of the spheres were used to calculate recovery coefficients for each target-to-background ratio and for different reconstruction algorithms. Whole-body time-of-flight PET/CT was performed in 20 patients 62±4 min after injection of 350±40 MBq (range 269–411 MBq)
18
F-FDG. From the acquired 2 min per bed position list mode data, simulated 1-min, 30-s and 15-s PET acquisitions were created. PET images were reconstructed using the TOF-OSEM algorithm and analysed for differences in SUV measurements resulting from the use of lower administered activity as simulated by reduced count statistics.
Results
In the phantom studies, overall we identified no significant quantitation bias over a wide range of acquired counts. With acquisition times as short as 10 s, lesions as small as 1 cm in diameter could still be identified. In the patient studies, visual analysis showed that emission scans as short as 15 s per bed position sufficiently identified tumour lesions for quantification. As the acquisition time per bed position decreased, the differences in SUV quantification of tumour lesions increased relative to the 2-min reference protocol. However, SUVs remained within the limits of reproducibility required for therapy monitoring. Measurements of SUVmean within the region of interest were less prone to noise than SUVmax, and with the 30-s per bed position 95% confidence limits were ±11% or ±0.7 SUV.
Conclusion
Short time acquisitions, synonymous with reduced injected activity, performed on a TOF-based PET/CT system are feasible without encountering significant bias. This could translate into clinical protocols using lower administered activities particularly for serial PET studies.</description><identifier>ISSN: 1619-7070</identifier><identifier>EISSN: 1619-7089</identifier><identifier>DOI: 10.1007/s00259-010-1466-5</identifier><identifier>PMID: 20428866</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adult ; Cancer ; Cardiology ; Humans ; Imaging ; Medical imaging ; Medicine ; Medicine & Public Health ; Neoplasms - diagnosis ; Neoplasms - diagnostic imaging ; Neoplasms - therapy ; Nuclear Medicine ; Oncology ; Original Article ; Orthopedics ; Phantoms, Imaging ; Positron-Emission Tomography - methods ; Radiology ; Reproducibility of Results ; Therapy ; Time Factors ; Tomography, X-Ray Computed - methods ; Treatment Outcome</subject><ispartof>European journal of nuclear medicine and molecular imaging, 2010-08, Vol.37 (9), p.1643-1653</ispartof><rights>Springer-Verlag 2010</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c436t-85778430854d8d58f17654e685c51c1da2e5f22021011d0ac925bbbcaac4437f3</citedby><cites>FETCH-LOGICAL-c436t-85778430854d8d58f17654e685c51c1da2e5f22021011d0ac925bbbcaac4437f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00259-010-1466-5$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00259-010-1466-5$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,777,781,27905,27906,41469,42538,51300</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20428866$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Murray, Iain</creatorcontrib><creatorcontrib>Kalemis, Antonis</creatorcontrib><creatorcontrib>Glennon, Joe</creatorcontrib><creatorcontrib>Hasan, Syed</creatorcontrib><creatorcontrib>Quraishi, Shuaib</creatorcontrib><creatorcontrib>Beyer, Thomas</creatorcontrib><creatorcontrib>Avril, Norbert</creatorcontrib><title>Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring</title><title>European journal of nuclear medicine and molecular imaging</title><addtitle>Eur J Nucl Med Mol Imaging</addtitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><description>Introduction
Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy of quantitative measures using time-of-flight PET/CT.
Methods
We evaluated the effect of reducing the emission count statistics, using a 64-channel GEMINI TF PET/CT system. Experiments were performed with the NEMA IEC body phantom at target-to-background ratios of 4:1 and 10:1. Emission data for 10 s, 30 s, 1 min, 2 min, 5 min and 30 min were acquired. Volumes of interest fitted to the CT outline of the spheres were used to calculate recovery coefficients for each target-to-background ratio and for different reconstruction algorithms. Whole-body time-of-flight PET/CT was performed in 20 patients 62±4 min after injection of 350±40 MBq (range 269–411 MBq)
18
F-FDG. From the acquired 2 min per bed position list mode data, simulated 1-min, 30-s and 15-s PET acquisitions were created. PET images were reconstructed using the TOF-OSEM algorithm and analysed for differences in SUV measurements resulting from the use of lower administered activity as simulated by reduced count statistics.
Results
In the phantom studies, overall we identified no significant quantitation bias over a wide range of acquired counts. With acquisition times as short as 10 s, lesions as small as 1 cm in diameter could still be identified. In the patient studies, visual analysis showed that emission scans as short as 15 s per bed position sufficiently identified tumour lesions for quantification. As the acquisition time per bed position decreased, the differences in SUV quantification of tumour lesions increased relative to the 2-min reference protocol. However, SUVs remained within the limits of reproducibility required for therapy monitoring. Measurements of SUVmean within the region of interest were less prone to noise than SUVmax, and with the 30-s per bed position 95% confidence limits were ±11% or ±0.7 SUV.
Conclusion
Short time acquisitions, synonymous with reduced injected activity, performed on a TOF-based PET/CT system are feasible without encountering significant bias. This could translate into clinical protocols using lower administered activities particularly for serial PET studies.</description><subject>Adult</subject><subject>Cancer</subject><subject>Cardiology</subject><subject>Humans</subject><subject>Imaging</subject><subject>Medical imaging</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neoplasms - diagnosis</subject><subject>Neoplasms - diagnostic imaging</subject><subject>Neoplasms - therapy</subject><subject>Nuclear Medicine</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Orthopedics</subject><subject>Phantoms, Imaging</subject><subject>Positron-Emission Tomography - methods</subject><subject>Radiology</subject><subject>Reproducibility of Results</subject><subject>Therapy</subject><subject>Time Factors</subject><subject>Tomography, X-Ray Computed - methods</subject><subject>Treatment Outcome</subject><issn>1619-7070</issn><issn>1619-7089</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kUFrGzEQhUVJaRwnP6CXIHLpSfVIK620uQXjpoVAe3DPQtZqbYXd1UbSpvjfd41dBwI9zQx88-YxD6HPFL5SALlIAExUBCgQysuSiA9oRktaEQmqujj3Ei7RVUrPAFQxVX1Clww4U6osZ2i39p0joSFN67e7jH-t1ovlGo_J91vchj_E2Oxffd7jIYYcbGjTPR5Cdn32psW-G1pvTfahT7gJEVvTWxdx3rlohj3uQu9ziJPYNfrYmDa5m1Odo9_fVuvld_L08_HH8uGJWF6UmSghpeIFKMFrVQvVUFkK7kolrKCW1oY50TAGjAKlNRhbMbHZbKwxlvNCNsUcfTnqTn5fRpey7nyyrm1N78KYtOSqYpIVciLv3pHPYYz9ZE4ryahkqqgmiB4hG0NK0TV6iL4zca8p6EMI-hiChsM8haDFtHN7Eh43navPG_--PgHsCKTh8BoX3y7_X_UvIL2R9A</recordid><startdate>20100801</startdate><enddate>20100801</enddate><creator>Murray, Iain</creator><creator>Kalemis, Antonis</creator><creator>Glennon, Joe</creator><creator>Hasan, Syed</creator><creator>Quraishi, Shuaib</creator><creator>Beyer, Thomas</creator><creator>Avril, Norbert</creator><general>Springer-Verlag</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20100801</creationdate><title>Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring</title><author>Murray, Iain ; Kalemis, Antonis ; Glennon, Joe ; Hasan, Syed ; Quraishi, Shuaib ; Beyer, Thomas ; Avril, Norbert</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c436t-85778430854d8d58f17654e685c51c1da2e5f22021011d0ac925bbbcaac4437f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adult</topic><topic>Cancer</topic><topic>Cardiology</topic><topic>Humans</topic><topic>Imaging</topic><topic>Medical imaging</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neoplasms - diagnosis</topic><topic>Neoplasms - diagnostic imaging</topic><topic>Neoplasms - therapy</topic><topic>Nuclear Medicine</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Orthopedics</topic><topic>Phantoms, Imaging</topic><topic>Positron-Emission Tomography - methods</topic><topic>Radiology</topic><topic>Reproducibility of Results</topic><topic>Therapy</topic><topic>Time Factors</topic><topic>Tomography, X-Ray Computed - methods</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Murray, Iain</creatorcontrib><creatorcontrib>Kalemis, Antonis</creatorcontrib><creatorcontrib>Glennon, Joe</creatorcontrib><creatorcontrib>Hasan, Syed</creatorcontrib><creatorcontrib>Quraishi, Shuaib</creatorcontrib><creatorcontrib>Beyer, Thomas</creatorcontrib><creatorcontrib>Avril, Norbert</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of nuclear medicine and molecular imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Murray, Iain</au><au>Kalemis, Antonis</au><au>Glennon, Joe</au><au>Hasan, Syed</au><au>Quraishi, Shuaib</au><au>Beyer, Thomas</au><au>Avril, Norbert</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring</atitle><jtitle>European journal of nuclear medicine and molecular imaging</jtitle><stitle>Eur J Nucl Med Mol Imaging</stitle><addtitle>Eur J Nucl Med Mol Imaging</addtitle><date>2010-08-01</date><risdate>2010</risdate><volume>37</volume><issue>9</issue><spage>1643</spage><epage>1653</epage><pages>1643-1653</pages><issn>1619-7070</issn><eissn>1619-7089</eissn><abstract>Introduction
Accurate quantification of tumour tracer uptake is essential for therapy monitoring by sequential PET imaging. In this study we investigated to what extent a reduction in administered activity, synonymous with an overall reduction in repeated patient exposure, compromised the accuracy of quantitative measures using time-of-flight PET/CT.
Methods
We evaluated the effect of reducing the emission count statistics, using a 64-channel GEMINI TF PET/CT system. Experiments were performed with the NEMA IEC body phantom at target-to-background ratios of 4:1 and 10:1. Emission data for 10 s, 30 s, 1 min, 2 min, 5 min and 30 min were acquired. Volumes of interest fitted to the CT outline of the spheres were used to calculate recovery coefficients for each target-to-background ratio and for different reconstruction algorithms. Whole-body time-of-flight PET/CT was performed in 20 patients 62±4 min after injection of 350±40 MBq (range 269–411 MBq)
18
F-FDG. From the acquired 2 min per bed position list mode data, simulated 1-min, 30-s and 15-s PET acquisitions were created. PET images were reconstructed using the TOF-OSEM algorithm and analysed for differences in SUV measurements resulting from the use of lower administered activity as simulated by reduced count statistics.
Results
In the phantom studies, overall we identified no significant quantitation bias over a wide range of acquired counts. With acquisition times as short as 10 s, lesions as small as 1 cm in diameter could still be identified. In the patient studies, visual analysis showed that emission scans as short as 15 s per bed position sufficiently identified tumour lesions for quantification. As the acquisition time per bed position decreased, the differences in SUV quantification of tumour lesions increased relative to the 2-min reference protocol. However, SUVs remained within the limits of reproducibility required for therapy monitoring. Measurements of SUVmean within the region of interest were less prone to noise than SUVmax, and with the 30-s per bed position 95% confidence limits were ±11% or ±0.7 SUV.
Conclusion
Short time acquisitions, synonymous with reduced injected activity, performed on a TOF-based PET/CT system are feasible without encountering significant bias. This could translate into clinical protocols using lower administered activities particularly for serial PET studies.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>20428866</pmid><doi>10.1007/s00259-010-1466-5</doi><tpages>11</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1619-7070 |
ispartof | European journal of nuclear medicine and molecular imaging, 2010-08, Vol.37 (9), p.1643-1653 |
issn | 1619-7070 1619-7089 |
language | eng |
recordid | cdi_proquest_miscellaneous_748927237 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Adult Cancer Cardiology Humans Imaging Medical imaging Medicine Medicine & Public Health Neoplasms - diagnosis Neoplasms - diagnostic imaging Neoplasms - therapy Nuclear Medicine Oncology Original Article Orthopedics Phantoms, Imaging Positron-Emission Tomography - methods Radiology Reproducibility of Results Therapy Time Factors Tomography, X-Ray Computed - methods Treatment Outcome |
title | Time-of-flight PET/CT using low-activity protocols: potential implications for cancer therapy monitoring |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T07%3A37%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Time-of-flight%20PET/CT%20using%20low-activity%20protocols:%20potential%20implications%20for%20cancer%20therapy%20monitoring&rft.jtitle=European%20journal%20of%20nuclear%20medicine%20and%20molecular%20imaging&rft.au=Murray,%20Iain&rft.date=2010-08-01&rft.volume=37&rft.issue=9&rft.spage=1643&rft.epage=1653&rft.pages=1643-1653&rft.issn=1619-7070&rft.eissn=1619-7089&rft_id=info:doi/10.1007/s00259-010-1466-5&rft_dat=%3Cproquest_cross%3E748927237%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=872172839&rft_id=info:pmid/20428866&rfr_iscdi=true |